McDermott International, Inc. (NYSE:MDR) Files An 8-K Other Events
Item 8.01 Other Events
McDermott International, Inc. (MDR) is filing this Current Report
on Form 8-K to provide a recast of the presentation of the
historical financial statements contained in our Annual Report on
Form 10-K for the year ended December 31, 2016 (the 2016 Form
10-K) filed with the Securities and Exchange Commission (the
“SEC”), to reflect changes to our reportable segments which
took effect in the first quarter of 2017. In this Form 8-K,
unless the context otherwise indicates, we, us and our mean MDR
and its consolidated subsidiaries, and references to any of the
Notes to the accompanying Consolidated Financial Statements refer
to the Notes to the Consolidated Financial Statements included in
Item 8 of Exhibit 99.1 to this report.
We report financial results under three reportable segments
consisting of (1) the Americas, Europe and Africa (AEA), (2) the
Middle East (MEA) and (3) Asia (ASA). We also report certain
corporate and other non-operating activities under the heading
Corporate and Other. Corporate and Other primarily reflects costs
that are not allocated to our reportable segments.
In the first quarter of 2017, we implemented certain changes to
our financial reporting structure, as follows:
Corporate expenses, certain centrally managed initiatives |
Research and development (RD) expenses are separately |
Gain (loss) on foreign currency, net is included in Other |
Our Note 19, Segment Reporting, to the accompanying |
We are filing this Current Report on Form 8-K to recast our
Consolidated Financial Statements as of December 31, 2016 and
2015 and for each of the years ended December 31, 2016, 2015 and
2014, to reflect the changes described above.The recast
Consolidated Financial Statements and revised notes to the
Consolidated Financial Statements are included in Exhibit 99.1 to
this report, which is incorporated by reference into this Item
8.01.Also included in Exhibit 99.1 is the report of our
independent registered public accounting firm on the Consolidated
Financial Statements, which is unchanged from the report included
in the 2016 Form 10-K, other than the dual date to reflect the
recast and reissuance. Except for minor, nonsubstantive
revisions, only the following notes have been revised from their
previous presentation:
Note 1, Basis of Reporting and Significant Accounting |
Note 3, Use of Estimates; |
Note 4, Restructuring; |
Note 8, Property, Plant and Equipment; |
Note 13, Fair Value Measurements; and |
Note 19, Segment Reporting. |
Similarly, the Managements Discussion and Analysis of Financial
Condition and Results of Operations (MDA) from the 2016 Form 10-K
has been recast to reflect the changes referred to above.The
revised MDA presentation is also included in Exhibit 99.1 to this
report.
The changes referred to above had no impact on our historical
consolidated financial position, results of operations or cash
flows, as reflected in the recast Consolidated Financial
Statements contained in Exhibit 99.1 to this report.The recast
Consolidated Financial Statements do not represent a restatement
of previously issued consolidated financial statements.
This report, including Exhibit 99.1, does not reflect events
occurring after the filing of the 2016 Form 10-K and does not
modify or update the disclosures in the 2016 Form 10-K, other
than as required to reflect the changes described above. Without
limitation of the foregoing, this report does not purport to
update the MDA contained in the 2016 Form 10-K for any
forward-looking statements. More current information is contained
in our Quarterly Report on Form 10-Q for the quarterly period
ended March 31, 2017 and our Current Reports on Form 8-K filed
with the SEC with respect to events occurring after December 31,
2016. This report should be read in conjunction with the 2016
Form 10-K, our Form 10-Q for the quarterly period ended March 31,
2017 and our Current Reports on Form 8-K filed subsequent to the
2016 Form 10-K. The Exhibits provided with this Form 8-K shall be
deemed to be “filed” for purposes of the Securities Exchange
Act of 1934, as amended.
Item 9.01 Financial Statements and Exhibits
(d) Exhibits
Consent of Deloitte Touche LLP |
||
99.1 |
Revised Part IIItem 7. Managements Discussion and |
|
The following revised materials from the Company’s |
McDermott International, Inc. (NYSE:MDR) Recent Trading Information
McDermott International, Inc. (NYSE:MDR) closed its last trading session at with 2,671,443 shares trading hands.